Latest News and Press Releases

NEWARK, Del, March 23, 2025 (GLOBE NEWSWIRE) -- The global autoimmune disease therapeutics market is set to experience significant expansion, with projections indicating an increase from...

New York, United States, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Biosimilars, also known as follow-on biologics, are made by a different business but look and work much like the original medicine....

New York, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Myasthenia Gravis Treatment Market Poised for Steady Growth, driven by Innovation and Rising Awareness The global market for myasthenia gravis (MG)...

Wilmington, Delaware, United States, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The autoimmune disease diagnostics market was estimated to have acquired US$ 14.4 billion in 2018.  It is anticipated to...

New York, March 21, 2023 (GLOBE NEWSWIRE) -- The Insight Partners, “Human Microbiome Market Size, Share, Trends, Growth and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), is a patient-focused, innovative, commercial-stage, global...

DUBLIN, Sept. 27, 2021 (GLOBE NEWSWIRE) -- David Sanders, MD, is a professor of Gastroenterology and a Consultant Gastroenterologist at the Royal Hallamshire Hospital & the University of...

- Successful generation of INVA8003, a peptidomimetic inhibitor of PYCARD (often referred to as ASC, apoptosis-associated speck-like protein containing CARD) triggers milestone payment to PRISM BioLab...

Collaboration to expand and accelerate global development of efgartigimod; expected to allow argenx to more rapidly advance new potential indications into clinical development each yearZai Lab granted...

Silver Spring, Maryland, USA, May 28, 2019 (GLOBE NEWSWIRE) -- Sakina A. Ansari-Wilson, an evidence-based energy healer, today announces research based on the impact of a biofield energy treated...